Chronic wounds remain a major health care challenge, especially for people with diabetes, who often experience delayed ...

EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart ...

Please provide your email address to receive an email when new articles are posted on . In patients with gestational diabetes, use of inhaled insulin was comparable ...

Please provide your email address to receive an email when new articles are posted on . CGM improved HbA1c, time in range and other metrics over 26 weeks. CONNECT trial suggests CGM can be considered ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

New research examines how a Chinese company struggled to develop its predictive surveillance technology while U.S. restrictions were in place. The skyline of Beijing. A Chinese firm is working on ...

What Is Afrezza, and Why Does It Matter? Afrezza is a fast-acting insulin that you breathe in as you start a meal. It lowers blood sugar by helping your muscles and fat use sugar and by telling your ...

A prospective study showed that serum levels of eleven acylcarnitines were associated with the rate of decline in estimated glomerular filtration rate (eGFR) among patients with type 2 diabetes (T2D).

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the fascinating possibility that ...

Before his company’s epic bankruptcy, Ryan Kavanaugh pitched Hollywood that he could predict box office winners with his “Monte Carlo” algorithm. We all know how that turned out, but that hasn’t ...

A large European study uncovers hidden cardiovascular risk patterns in type 1 diabetes, showing how smarter profiling could help doctors catch complications earlier and tailor prevention. Study: ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...